TY - JOUR
T1 - Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
AU - Lee, Sooji
AU - Son, Yejun
AU - Hwang, Jiyoung
AU - Kim, Min Seo
AU - Shin, Jae Il
AU - Yon, Dong Keon
AU - Kassebaum, Nicholas J.
AU - Abate, Semagn Mekonnen
AU - Abate, Yohannes Habtegiorgis
AU - Elhafeez, Samar Abd
AU - Abd-Elsalam, Sherief
AU - Abdoun, Meriem
AU - Abdulkader, Rizwan Suliankatchi
AU - Abdullahi, Auwal
AU - Abebe, Mesfin
AU - Abedi, Armita
AU - Abie, Alemwork
AU - Abiodun, Olumide
AU - Aboagye, Richard Gyan
AU - Abolhassani, Hassan
AU - Abouzid, Mohamed
AU - Abreu, Lucas Guimarães
AU - Abualruz, Hasan
AU - Abukhadijah, Hana J.
AU - Aburuz, Salahdein
AU - Abu-Zaid, Ahmed
AU - Adamu, Lawan Hassan
AU - Adane, Mesafint Molla
AU - Addo, Isaac Yeboah
AU - Adegboye, Oyelola A.
AU - Adekanmbi, Victor
AU - Adetunji, Charles Oluwaseun
AU - Adeyeoluwa, Temitayo Esther
AU - Adnani, Qorinah Estiningtyas Sakilah
AU - Adzigbli, Leticia Akua
AU - Afzal, Saira
AU - Agampodi, Suneth Buddhika
AU - Agyemang-Duah, Williams
AU - Ahmad, Aqeel
AU - Ahmad, Muayyad M.
AU - Ahmad, Shahzaib
AU - Ahmad, Tauseef
AU - Ahmed, Ali
AU - Ahmed, Ayman
AU - Ahmed, Haroon
AU - Ahmed, Mehrunnisha Sharif
AU - Ahmed, Syed Anees
AU - Ajami, Marjan
AU - Akinosoglou, Karolina
AU - Akter, Ema
AU - Al Awaidy, Salah
AU - Al Hasan, Syed Mahfuz
AU - Al Omari, Omar
AU - Alajlani, Muaaz M.
AU - Al-Aly, Ziyad
AU - Al-Amer, Rasmieh Mustafa
AU - Albashtawy, Mohammed
AU - Aldhaleei, Wafa A.
AU - Algammal, Abdelazeem M.
AU - Alhalaiqa, Fadwa Naji
AU - Ali, Abid
AU - Ali, Akhtar
AU - Ali, Liaqat
AU - Ali, Mohammed Usman
AU - Ali, Syed Shujait
AU - Ali, Waad
AU - Samakkhah, Shohreh Alian
AU - Alif, Sheikh Mohammad
AU - Al-Marwani, Sabah
AU - Al-Mekhlafi, Hesham M.
AU - Almustanyir, Sami
AU - Alqahtani, Jaber S.
AU - Al-Raddadi, Rajaa M.Mohammad
AU - Alsabri, Mohammed A.
AU - Altaany, Zaid
AU - Altaf, Awais
AU - Al-Tammemi, Alaa B.
AU - Altirkawi, Khalid A.
AU - Aly, Hany
AU - Alzoubi, Karem H.
AU - Amani, Reza
AU - Amiri, Sohrab
AU - Amu, Hubert
AU - Amusa, Ganiyu Adeniyi
AU - Ancuceanu, Robert
AU - Andrei, Tudorel
AU - Anuoluwa, Boluwatife Stephen
AU - Anuoluwa, Iyadunni Adesola
AU - Anvari, Saeid
AU - Anwar, Sumadi Lukman
AU - Anyasodor, Anayochukwu Edward
AU - Arabloo, Jalal
AU - Arafat, Mosab
AU - Aravkin, Aleksandr Y.
AU - Areda, Demelash
AU - Aregawi, Brhane Berhe
AU - Aremu, Abdulfatai
AU - Ariffin, Hany
AU - Arkew, Mesay
AU - Ni, Ketut Aryastami
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Purpose Renal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea. Materials and Methods From January 2001 to December 2015, data of pediatric patients (0-18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed. Results Among 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range, 0 to 225.5 months) and median follow-up duration was 88.5 months (range, 0 to 211.6 months). Overall, 32 patients died, of whom 17, 11, 1, and three died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event-free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001). Conclusion The pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea.
AB - Purpose Renal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea. Materials and Methods From January 2001 to December 2015, data of pediatric patients (0-18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed. Results Among 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range, 0 to 225.5 months) and median follow-up duration was 88.5 months (range, 0 to 211.6 months). Overall, 32 patients died, of whom 17, 11, 1, and three died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event-free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001). Conclusion The pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea.
UR - https://www.scopus.com/pages/publications/105026873893
U2 - 10.4143/crt.2022.073
DO - 10.4143/crt.2022.073
M3 - Article
C2 - 35952715
AN - SCOPUS:105026873893
SN - 1598-2998
VL - 55
SP - 279
EP - 290
JO - Cancer Research and Treatment
JF - Cancer Research and Treatment
IS - 1
ER -
SDG 3 Good Health and Well-being